Diagnostic Pap Smear Tests To Be Considered For National Medicare Policy
This article was originally published in The Gray Sheet
Executive Summary
Diagnostic Pap smear procedures will be evaluated as to whether they warrant a national Medicare coverage policy by the Health Care Financing Administration's negotiated rulemaking committee for clinical laboratory diagnostic tests.